What is CorMedix's change in AP?

CorMedix (CRMD) reported change in AP of $4.94M in Q1 2026.

How has CorMedix's change in AP changed year-over-year?

CorMedix's change in AP increased by 2220.7% year-over-year, from $213K to $4.94M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

CorMedix CRMD Change in AP

Change in AP at other companies

PfizerPFE

-$117.25M+54.2%

Merck & Co.MRK

$27.5M-39.6%

Merit Medical SystemsMMSI

$4.49M+0.9%

ITG

Integer HoldingsITGR

$9.44M-7.5%

IAR

Integra LifeSciencesIART

-$19.19M-6.6%

Emergent BiosolutionsEBS

-$14.4M-167%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's change in AP?: CorMedix (CRMD) reported change in AP of $4.94M in Q1 2026.
How has CorMedix's change in AP changed year-over-year?: CorMedix's change in AP increased by 2220.7% year-over-year, from $213K to $4.94M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.